Advertisement
Advertisement

AKBA

AKBA logo

Akebia Therapeutics, Inc.

0.91
USD
Sponsored
-0.04
-4.66%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

0.91

0.00
+0.12%

Akebia Therapeutics, Inc. Profile

About

Akebia Therapeutics Inc. is a biopharmaceutical company. It focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor biology for patients with kidney disease. Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

Info & Links

CEO

John P. Butler

Headquarters

245 FIRST STREET,SUITE 1100
CAMBRIDGE, MA 02142, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

http://www.akebia.com

Auditor

Ernst & Young LLP

Share holders

25

Employees

194

Akebia Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

252.44M

Enterprise Value

146.46M

Enterprise Value/EBITDA(ttm)

-10.79

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.15

Price to Book(mrq)

10.08

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

79.53%

Operating Margin(ttm)

-12.84%

Profit Margin(ttm)

-13.84%

Return on Equity(ttm)

-88.88%

Return on Invested Capital(ttm)

-46.63%

Return on Assets(ttm)

-7.74%

Income Statement

Revenue(ttm)

219.06M

Revenue Per Share(ttm)

0.79

Gross Profit(ttm)

174.43M

EBITDA(ttm)3

-13.57M

Net Income Available to Common(ttm)

-29.67M

Diluted EPS(ttm)

-0.11

Share Statistics

Beta (5Y Monthly)

0.26

52-Week Change

-69.77%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

277.11M

Dividend Yield

0.00%

Float4

265.19M

% Held by Insiders

4.30%

% Held by Institutions

33.92%

Balance Sheet

Total Cash(mrq)

155.55M

Total Cash Per Share(mrq)

0.56

Total Debt(mrq)

49.56M

Total Debt/Equity(mrq)

198.11%

Current Ratio(mrq)

1.43%

Quick Ratio(mrq)

1.33%

Book Value Per Share(mrq)

0.09

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.07

Free Cash Flow(ytd)

-18.82M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement